Abstract
AbstractBidirectional signaling is an essential feature of αIIbβ3 function. The αIIb cytoplasmic domain negatively regulates β3-mediated inside-out signaling, but little is known about the regulation of αIIb-mediated outside-in signaling. We show that αIIb-mediated outside-in signaling is enhanced in platelets of a patient lacking the terminal 39 residues of the β3 cytoplasmic tail. This enhanced signaling was detected as thromboxane A2 (TxA2) production and granule secretion, and required ligand cross-linking of αIIbβ3 and platelet aggregation. This outside-in signaling was specifically inhibited by a palmitoylated version of a β3 peptide corresponding to cytoplasmic domain residues R724-R734. Unlike the palmitoylated peptide, the nonpalmitoylated β3 peptide could not cross the platelet membrane and did not inhibit this outside-in signaling. The physiologic relevance of this β3-mediated negative regulation of αIIb outside-in signaling was demonstrated in normal platelets treated with the palmitoylated peptide and a physiologic agonist. Binding of αIIbβ3 complexes to immobilized peptides demonstrated that a peptide corresponding to β3 residues R724-R734 appears to bind to an αIIb cytoplasmic domain peptide containing residues K989-D1002, but not to control peptides. These results demonstrate that αIIb-mediated outside-in signaling resulting in TxA2 production and granule secretion is negatively regulated by a sequence of residues in the membrane distal β3 cytoplasmic domain sequence RKEFAKFEEER.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.